In this paper, the performance of a control law designed for the automatic administration of propofol and of remifentanil in order to track a desired level for the bispectral index (BIS), used as a measure of the depth of anesthesia, is analyzed under the presence of model parameters uncertainties. It is theoretically proved and illustrated by simulations that under these circumstances the controller has a very good performance as the BIS converges to a value contained in a neighborhood of the desired BIS level. a retuning strategy in order to improve the BIS tracking under the presence of uncertainties was also theoretically deduced. Simulations show that this strategy leads to BIS tracking improvement. The performance of the controller in clinical environment is illustrated by a clinical case.
Introduction
Correct administration of anesthesia drug is crucial for the success of surgery.
In this regard, the controllers developed for automatic administration of drugs have to be extensively studied. It is important to study the performance of the controller under the presence of modeling errors as the complex nature of the human body and the inter-and intra-individual variability do not allow obtaining an exact description of the drug e ect in each patient.
In this sense, it is also crucial to develop retuning techniques to calibrate the controller in order to address possible misfits between the obtained results and the desired values, arising not only from modeling errors, but also from noisy measurements.
Here, the focus is the administration of the hypnotic propofol and of the analgesic remifentanil. These drugs are used for the control of the depth of anesthesia (DoA). The DoA is related to the intensity of two components of general anesthesia: analgesia and hypnosis. According to several studies (Tirén et al. [1] , Grindsta and Tobias [2] , Ekman et al. [3] , Wodey et al. [4] , Whyte and Booker [5] ) the DoA may be measured by means of the bispectral index (BIS). This index is a single dimensionless number, which is computed from the electroencephalogram (EEG) and ranges from 0 (equivalent to EEG silence) to 100 (equivalent to fully awake and alert). According to clinical experience, a BIS value between 40 and 60 is desirable for general anesthesia purposes, as it usually corresponds to an adequate state of uncon-sciousness during surgical procedures. This is usually achieved manually by the anesthesiologists. However, due to the high complexity of this procedure, an automated system for drug administration would be a good support for the clinicians. This question has deserved the attention of several researchers and led to a number of contributions and controlleres namely a predictive control in Ionescu et al. [6] , an adaptive model-based controller in Mortier et al. [7] and Simanski et al. [8] , a PID in Padula et al. [9] , a neural in Ortolani et al. [10] , a fuzzy logic in Shieh et al. [11] , a model predictive control in Sawaguchi et al. [12] and Chang et al. [13] . but in these contributions the control of the DoA is not fully automatic. More concretely, the administration of the hypnotic is made automatically, however the administration of the analgesic is made manually by the anesthetic. A detailed introduction to anesthesia as a control problem together with a good overview of the state of the art can be found in Lemos et al. [14] and Dumont [15] .
In Nogueira et al. [16] a control law was proposed for the BIS tracking of patients, during general anesthesia, by means of the automatic administration of propofol and of refimentanil. This controller has the advantage of allowing di erent combinations of drugs in order to obtain the same value for the BIS level, it allows the changing of the desired reference value for the BIS during the surgical procedure, and it is already used in clinical practices, with good performance according to the anesthesiologists. The big difference between this controller and the aforementioned controllers cited above is that: in the referred works the BIS is controlled by the automatic administration of one single drug (the hypnotic) together with the manual administration of the other drug (the analgesic), by the anesthesiologist, whereas in Nogueira et al. [16] these two drugs are automatically administered, without any intervention of the anesthesiologist.
The aim of this work is to study the performance of the controller proposed in Nogueira et al. [16] under the presence of model parameters uncertainties. It is theoretically proved that under these circumstances, the BIS level converges to a value contained in a neighborhood of the desired BIS level.
This fact allows a retuning strategy in order to recalibrate the controller for BIS tracking improvement. The theoretical deduction of this strategy is here presented.
The structure of this paper is as follows. Section 2 is devoted to the explanation of the BIS model, while the control law is presented in Section 3.
In Section 4 the robustness of the controller is analyzed and in Section 5 an on-line retuning strategy is theoretically deduced. Simulations are illustrated in Section 6 while a clinical case is presented in Section 7. Conclusions are drawn in Section 8.
Model description
The patient BIS level obtained by means of the administration of the hypnotic propofol and of the analgesic remifentanil may be modeled by a new Wiener model recently introduced in the literature Silva et al. [17] and known as the parameter parsimonious model (PPM). According to this model, the linear relations between the propofol and remifentanil dosages and the correspond-ing e ect concentrations (c p e and c r e ) are modeled by the transfer functions:
respectively, where -and ÷ are patient dependent parameters, without any explicit physiological meaning, k 1 , k 2 , k 3 and l 1 , l 2 , l 3 are dimensionless constants whose values were identified in Silva et al. [17] from a real patient database, as: [18] , is approximated in Silva et al. [17] by the nonlinear equation:
where U = µ c p the work developed in Mendonça et al. [19] .
The PPM may be also represented by the following state space representation:
where C = 5 0 0 0.1µ 0 0 100
This specific form of the state space realization has compartmental structure. This has the advantage of allowing the use of the positive control law defined in the next section.
Controller description
The nonlinear controller presented in Nogueira et al. [16] was designed for the automatic administration of propofol and of remifentanil in order to control the BIS level of a patient. This control law, which results from a combination of a linear controller with a positivity constraint for the drug doses, is defined by:
where u p is the input of propofol and u r is the input of remifentanil, with:
and For more details about this controller and its tracking properties, the reader is referred to Nogueira et al. [16] .
The robustness of the controller (6) is analyze in the next section.
Controller robustnes in the presence of uncertainties in the linear part of the PPM
Here it will be proven that the controller (6) is robust under the presence of uncertainties in the linear part of the PPM. More concretely, in this case, the BIS of the patient will converge to a value contained in a neighborhood of the desired reference for the BIS level. This is acceptable from the clinical point of view, as, in clinical practice, the BIS level should be contained in an interval, usually between 40 and 60.
Instead of the real values for the parameters -and ÷, estimates for those values,-and÷, are respectively used. This implies that instead of using u as described in (11) , for the automatic administration of propofol and of remifentanil, the controllerû as described below is used.
with:û
where
and
.
the matrixÊ may be written as:
and thenû may be written aŝ
In the sequel, it is proven that whenû is applied to the PPM, as described in (4), the obtained BIS value converges to a steady state value in a neighborhood of the desired BIS level. For this purpose, the auxiliary output
is considered.
1
In particular, when M (x) converges to M ú (as in equation (9)), the BIS level of the patient converges to the reference value z ú . Now, let:
and KA = KA ≠ KÂ, and let:
with 1 This auxiliary output was used in Nogueira et al. [16] , in the context of control without model uncertainties, where it was proven that when M (x) converges toM , the BIS level
Applying the LaSalle's invariance principle (see LaSalle [20] ) to the Lyapunov
It will be shown next, by proving thatV (x) AE 0, 'x oe R n + , that the continuous function V (x) is indeed a LaSalle-Lyapunov function of the system on R n + . For this, it has be taken into account that:
(29)
SinceV
withṀ (x) = Kẋ = KAx + KBû, is defined piecewise, the analysis of the non positivity ofV (x) into two cases has to be made. First it is considered that M (x) <M min and it is proved that in this case M (x) > 0, implying thatV < 0. Secondly, the case when M (x) >M max is studied. In particular, M (x) < 0 andV < 0 is verified. 
The relation between expressions (36) and (37) is due to the fact that every a oe R satisfies a Ø ≠|a|, whereas the relation between expressions (37) and (38) results from (28) and (30).
because all the components of x are nonnegative. Ifû > 0, thenû =û anḋ M (x) becomes (see equation (36)):
for k⁄ > | ks |.
Hence, it may been concluded that choosing the parameter ⁄ large enough,
is non positive during all time. Then, by the LaSalle's invariance principle, all system trajectories, x(t), converge to the largest set contained in
which is forward-invariant under the closed-loop dynamics. It follows from (31) thatV (x) = 0 either when u =ũ and
, or when u = 0, which implies that M (x) > M ú , and KAx = 0. Then
The set I 4 is not invariant. In fact, ifû would remain equal to zero, at a certain time instant, M (x) would become smaller than M ú ,û(x) would become positive, andû(x) would equalû(x), so the trajectory x(t) would leave the subset. On the other hand, both I 1 , I 2 and I 3 are subsets of I M , which is invariant, indeed if M (x) AEM min , thenṀ (x) Ø 0 and if M (x) ØM max , thenṀ (x) AE 0. Therefore, one may conclude that M (x) converges to (a subset contained in) the interval I M as previously claimed.
Since the patient BIS response to the administered drug dosesû is a decreasing function of M (x) (cf. equation (18)), the BIS level converges to the interval: 
As expected, the desired steady state value z ú is not achieved, but the pa- Note that:
thus, if -and ÷ converge to zero k clearly converges to the value 1.
As it shall be next proven, in the presence of uncertainties in the PPM linear part, the BIS of the patient not only remains in the interval I BIS , but also converges to a specific valuez oe I BIS .
Retuning improvement in the presence of uncertainties in the PPM linear part
In Nogueira et al. [21] , a retuning strategy was proposed in order to overcome the discrepancy between the obtained BIS level for the patient and the desired one. As already mentioned this may be the result of modeling errors and measurement noise. This strategy consists of computing another reference value for M ú in (7), by assuming that, in spite of the presence of modeling errors, the BIS converges to a determined value and assuming also that there is a proportion between the obtained BIS value and the reference value M ú .
Here the specific case where the misfit between the desired BIS value and the obtained one is due to the presence of errors in the PPM linear part parameters is analyzed. Moreover, it is theoretically proven that the patient BIS indeed converges to a specific valuez, which allows the computation of a new reference for M ú for recalibration of the control law (16) . More concretely, it will be proven that the auxiliary output M (x) will converge to a valueM , which is equivalent to have the BIS converging to the valuē z = In order to prove that M (x) converges to a valueM , it will be first proved that after a certain instant t Á ,û will remain nonnegative. Then, it will be proved that, in this case, there is only one equilibrium point. After finding the equilibrium point the controller may be recalibrated.
In the previous section, it was proved that under the presence of uncertainties in the linear part of the PPM, the auxiliary output M (x) remains in
Thus, for every Á Ø 0:
Note that û Ø 0 ( 6 8 )
By (28), the following inequalities hold
Consider (see (71) and (75)):
which is equivalent to
Thus, for
Prove that for all t Ø t Á , there is one equilibrium point.
According to the demonstration conducted above, there exists a certain in-
When M (x) = M ú , i.e, whenṀ = 0, the controlû is then given byû = ≠EKAx, and the closed-loop system can be described bẏ
In Nogueira et al. [16] it was shown that the system (85) is stable with the equilibrium point, x eq , described by:
where c r e is the e ect concentration of remifentanil.
Thus, by (81) and (86), the solution of the system
is computed by the following equation:
which is equivalent to:c
for suitable S, that may be determined by observing the BIS value of the patient. More concretely, and noting that the value of M ú is known, after the e ect concentration of remifentanil,c r e , be computed by inverting the Hill equation, S may be determine by the following expressions:
wherez is the BIS of the patient andŪ is the corresponding potency.
In order to improve the convergence of the BIS, the reference value M ú in the controller (16) is replaced for another reference value M úú . The reference M úú must be such that the e ect concentration of remifentanil,c r e , obtained by using it would be equal to the desired e ect concentration of remifentanil, c rú e , i.e., the following equality must hold:
By (89), this would be equivalent to:
Which means that
= 0.1µfl + 100
= 1
Concluding, in the presence of uncertainties in the linear part of the PPM, the BIS of the patient will converge to a certain valuez, instead of converging to the desired one z ú . This problem may be overcome, by observing the BIS at steady-state,z, and retuning the control law replacing the reference value M ú for the new reference value M úú computed as in (98).
It is noteworthy that the formula (98) here deduced to compute the reference M úú is the same as the one proposed in Nogueira et al. [21] . This is due to the fact that, although it was not proved in the work presented in Nogueira et al. [21] , it was assumed that the BIS converges to a single value and that there is a proportion between the obtained BIS valuez and the reference BIS value M úú , which actually happens when there are errors in the identification of the parameters of the linear part of the PPM, as it was proved in this work. given by
This corresponds to using equation ( 
Simulations
In this section, the performance of the controller (6), proposed in Nogueira et al. [16] , under the presence of uncertainties in the parameters of the linear part of the PPM and the performance of the retuning strategy here proposed are illustrated by means of simulations. Note that although the presented models and control law are in continuous time, they are discretized for implementation (by means of a zoh).
The simulated patients were set up based on the data of real patients subjected to general anesthesia under propofol and remifentanil administration.
The DoA was monitored by the BIS level and was manually controlled around
clinically accepted values by the anesthetist. Alaris GH pumps were used for both propofol and remifentanil. Infusion rates, BIS values and other physiological variables were acquired every five seconds (Mendonça et al. [19] ).
In Figure 1 the BIS evolution of a patient is illustrated where the test patient was considered to be modeled by a PPM with realistic parameters: -= 0.086, ÷ = 0.021, µ = 1.42, and " = 0.98 (see Mendonça et al. [19] ). On the other hand, the control law (11) was tuned with the design parameters ⁄ = 100 and fl = 900, and was tuned for the estimated parameters-= 50-and÷ = 50÷. The desired reference value for the BIS, z ú , was set to be 50.
As theoretically proved, the BIS converged to a valuez that belongs to the interval
with BIS min = 42 and BIS max = 56. As it may observed, in Figure 1 , the BIS response of the patient converged to 54 rather than to the desired reference value, z ú = 50, i.e., the BIS was a ected by an error of 8%. The new reference M ú was computed, as in (98), at time t 0 = 40 min, improving the BIS response of this patient, which converged to 48.5 representing an error of 3%. The reference value for the BIS level was set to be 50.
In order to test the performance of the retuning strategy under more adverse circumstances, six patients are simulated by six PK/PD Wiener models (other than the PPM) described in Appendix A. The nonlinear part was taken to coincide with the generalized Hill equation (3) and the corresponding parameters " and µ were identified in Mendonça et al. [19] from the surgery data (see Table B. 3). The values of EC p 50 and EC r 50 are respectively 10 mg/ml and 0.01 mg/ml, as previously mentioned. It was also added to the BIS signal Gaussian white noise with zero mean and standard deviation ‡ noise = 3. In order to improve the performance of the control procedure in the presence of noise, a filter was applied to the noisy BIS signal. The misfit in the nonlinear part of the patient model was also increased.
More concretely, instead of the values " and µ, identified for the six patients (see Table B. 3), other values for " and µ were chosen in the PPM, namely " = 1.88 and µ = 1.79. These values are the average of the values for " and µ taken from a bank of identified values for eighteen real patients obtained in the work developed in Mendonça et al. [19] . As can be seen in Fig. 2 even in this adverse circumstance, the control of the BIS of the patient, with the retuning strategy applied at time instant t = 30 min also improved the tracking of the desired reference value, which was set to be 50, z ú = 50, and was a success from the clinical point of view, more concretely, 100% of the BIS value obtained were within 40 and 60, as desired.
The performance of the retuning strategy was also tested under extreme adversities. One hundred patients were simulated with PK/PD Wiener models (other than the PPM) described in Appendix A and were controlled with the control law as described in Nogueira et al. [16] , using the PPM. In The desired BIS level is set to be 50.
Clinical case
In this section, a clinical case is presented where the administration of propofol and remifentanil was automatically made by using the controller proposed in Nogueira et al. [16] , integrated in the Galeno platform (Costa et al. [22] ). According to the anesthesiologists, the performance of the controller is considered to be satisfactory. 
Appendix A. PK/PD Model Description
The e ect concentration of propofol (c p e ) and of remifentanil (c r e ) can be modeled by the PK/PD state space models given in Ionescu et al. [23] , based on the material presented in Bailey and Haddad [24] , Marsh et al. [25] , Minto et al. [26] , and Schnider et al. [27] , which have the following form: 
and, for the case of remifentanil (i=r): 
The lean body mass (lbm) for women and men are computed, respectively, by the equations 
Appendix B. Database
This database was courteously provided by Galeno project (http://www2.fc.up.pt/galeno/).
The parameters presented in Table B .2 were identified in Mendonça et al. [19] . 
